Clinical Outcomes Of Implantable Collamer Lens Implantation For The Correction Of Myopic Regression After Corneal Refractive Surgeries
Published 2023 - 41st Congress of the ESCRS
Reference: PO0973 | Type: Free paper | DOI: 10.82333/ka8m-sr87
Authors: Byoungwoo Ko* 1 , Seung Eun Lee 1 , Joon Hyun Kim 1
1Apgujeong Eye Clinic,Seoul,Korea, Republic Of
Purpose
To assess the surgical outcomes of implantable collamer lens (ICL) implantation in eyes with residual myopia after corneal refractive surgery.
Setting
Apgujeong Eye Clinic, Seoul, South Korea
Methods
A retrospective study comprised eyes of consecutive patients who underwent ICL implantation to correct myopia regression after corneal refractive surgeries, including photorefractive keratectomy (PRK) or laser-assisted in situ keratomileusis (LASIK). We assessed the safety, efficacy, predictability, stability, and adverse events preoperatively, at 6 months postoperatively.
Results
63 eyes (PRK: 42, LASIK:21) of 34 patients with a mean age of 35(range: 27-40), were included in this study. The preoperative manifest spherical equivalent refractive error was -2.42±1.03 D The pre-operative, post-operative 1day and post-operative 6months UDVA(logMAR) was 0.69 ±0.32, -0.02 ±0.08, and -0.02 ± 0.09, respectively. The mean indices for safety and efficacy were 1.09 ±0.12 and 1.08 ±0.19, respectively. At 6 months postsurgery, 59 and 63 of the eyes were within ±0.5 and ±1.0 diopters (D), respectively, of the attempted spherical equivalent correction. There were no obvious intraoperative and postoperative complications.
Conclusions
This study demonstrated that ICL implantation provided safe, effective, and predictable postoperative outcomes in eyes with myopic regression after previous corneal refractive surgeries.